Meridian Bioscience Inc offers ImmunoCard® Mycoplasma, a rapid enzyme immunoassay that is an in vitro qualitative procedure for the detection of IgM to Mycoplasma pneumoniae in human serum. Test results are intended to aid in the diagnosis of recent Mycoplasma pneumoniae infections. The ImmunoCard Mycoplasma is a self-contained device with color-change technology used in the diagnosis of early/acute disease phase. The assay is a simple, four-step procedure with no calculations that gives results within 9 minutes. The ImmunoCard Mycoplasma is the only membrane test that detects IgM antibody.
Meridian Bioscience Inc
(513) 271-3700; www.meridianbioscience.com
